While PFS is a valuable endpoint, it has some limitations. One major limitation is that it does not account for the overall survival (OS) of the patient, which is the ultimate measure of treatment efficacy. Additionally, PFS can be influenced by the frequency and method of disease assessment, introducing potential biases. It also may not fully capture the patient's quality of life during the treatment.
